Vulvar SCC represents 90% of all vulvar cancers and typically develops by one of two different pathways.

Figure 1. Pathophysiology of usual-type and differentiated VIN and its progression to SCC. Suggested progression of usual-type (uVIN) and differentiated vulvar intraepithelial neoplasia (dVIN) to SCC.